Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema (left eye)
ICD-10 E10.3392 is a billable code used to indicate a diagnosis of type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema (left eye).
E10.3392 refers to a specific condition in which a patient has Type 1 diabetes mellitus accompanied by moderate nonproliferative diabetic retinopathy affecting the left eye, without the presence of macular edema. Type 1 diabetes is characterized by the autoimmune destruction of insulin-producing beta cells in the pancreas, leading to absolute insulin deficiency. Diabetic retinopathy is a common complication of diabetes, resulting from damage to the retinal blood vessels due to chronic hyperglycemia. Moderate nonproliferative diabetic retinopathy is identified by the presence of microaneurysms, retinal hemorrhages, and exudates, but without the more severe complications associated with proliferative diabetic retinopathy or macular edema. Management of this condition typically involves strict glycemic control, often monitored through HbA1c levels, which should ideally be maintained below 7% to prevent further retinal damage. Insulin therapy is essential for Type 1 diabetes management, and regular ophthalmologic evaluations are crucial for monitoring the progression of retinopathy.
Detailed records of diabetes management, including insulin regimen and HbA1c levels.
Patients presenting with uncontrolled diabetes, requiring insulin adjustments.
Ensure documentation reflects the type of diabetes and any complications.
Comprehensive eye examination reports detailing retinopathy findings.
Routine diabetic eye exams for patients with known diabetes.
Document the presence or absence of macular edema and specify the eye affected.
Used during routine eye exams for diabetic patients.
Document findings of retinopathy and any changes in vision.
Ophthalmologists should ensure detailed documentation of retinopathy severity.
Specifying the eye affected is crucial for treatment planning and monitoring progression, as diabetic retinopathy can differ significantly between eyes.
